Timely development of vaccines against SARS-CoV-2

Timely development of vaccines against SARS-CoV-2

Saved in:

Bibliographic Details
Main Author:	Shan Lu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	Emerging Microbes and Infections
Online Access:	https://www.tandfonline.com/doi/10.1080/22221751.2020.1737580
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaccination against the SARS-CoV-2 in individuals with comorbidities
by: S A Berns, et al.
Published: (2025-02-01)

Acquired immunity against SARS‐CoV‐2 infection and vaccination
by: Laurent Renia, et al.
Published: (2023-11-01)

Booster vaccination against the SARS-CoV-2: mechanisms and efficiency
by: S. A. Berns, et al.
Published: (2023-12-01)

SARS-CoV-2 vaccine boosters: The time to act is now.
by: Maya Petersen, et al.
Published: (2021-12-01)

Immunogenicity of Vaccines Against SARS-CoV-2 In Patients With Rheumatic Diseases
by: B. B. BELOV, et al.
Published: (2022-09-01)

Pseudoneutralizing test for preclinical studies of vaccines against SARS-CoV-2
by: B. S. Cherepovich, et al.
Published: (2024-04-01)

Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
by: B. S. Belov, et al.
Published: (2022-03-01)

A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants
by: Marwa Alhashimi, et al.
Published: (2025-07-01)

Racing for a SARS‐CoV‐2 vaccine
by: Özlem Türeci, et al.
Published: (2021-09-01)

SARS-CoV-2 Alchemy: Understanding the dynamics of age, vaccination, and geography in the evolution of SARS-CoV-2 in India.
by: Mansi Patel, et al.
Published: (2025-03-01)

Risk factors and effectiveness of vaccination for nosocomial SARS-CoV-2 acquisition throughout the SARS-CoV-2 pandemic
by: Nishi Dave, et al.
Published: (2025-08-01)

Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
by: Xiaoqing Guan, et al.
Published: (2025-03-01)

COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2025-02-01)

A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
by: Nan Gao, et al.
Published: (2024-11-01)

Proposed therapies and vaccine developing for COVID-19 (SARS CoV-2)
by: Gamal, Abdelaziz, et al.
Published: (2020-06-01)

Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2
by: Mariyana Atanasova, et al.
Published: (2024-11-01)

Prevalence of Vaccination among Patients with SARS-CoV-2
by: Falah Hasan Obayes Al-Khikani
Published: (2024-07-01)

Pulmonary embolism after SARS-CoV-2 vaccination
by: Björn Zethelius, et al.
Published: (2024-12-01)

Correction: SARS-CoV-2 vaccines in patients with SLE
Published: (2021-04-01)

New Trends in SARS-CoV-2 Variants and Vaccines
by: Seik-Soon Khor
Published: (2025-03-01)

Serological assessment of the durability of vaccine-mediated protection against SARS-CoV-2 infection
by: John T. Bates, et al.
Published: (2024-12-01)

DNA vaccination induced protective immunity against SARS CoV-2 infection in hamsterss.
by: Kit Man Chai, et al.
Published: (2021-05-01)

Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients
by: Ioannis Tomos, et al.
Published: (2024-11-01)

Effectiveness and Immunogenicity of the MMR Vaccine Against SARS-CoV-2 Among Healthcare Workers
by: Hyeri Seok, et al.
Published: (2025-02-01)

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatic approach
by: V. Alamdari-Palang, et al.
Published: (2025-07-01)

Immunogenicity of monovalent and multivalent subunit vaccines against SARS-CoV-2 variants in mice with divergent vaccination history
by: Rui Wang, et al.
Published: (2025-08-01)

Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
by: Xueqiao Liu, et al.
Published: (2023-06-01)

Main Pharmacological Strategies Against SARS-CoV-2
by: Thais Gonçalves Fontes, et al.
Published: (2020-09-01)

Aptamer-engaged nanotherapeutics against SARS-CoV-2
by: Jing Zhang, et al.
Published: (2025-04-01)

Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
by: Shan Su, et al.
Published: (2021-01-01)

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
by: Haiyun Yu, et al.
Published: (2023-12-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
by: Mie Agermose Gram, et al.
Published: (2022-09-01)

Progress in combination vaccines and the co-administration of influenza virus and SARS-CoV-2 vaccines
by: Chengyu Hu, et al.
Published: (2025-06-01)

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
by: Monrat Chulanetra, et al.
Published: (2024-11-01)

Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach
by: Yasamin Pahlavan, et al.
Published: (2024-12-01)

Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
by: Sumera Zaib, et al.
Published: (2022-11-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
by: Linda Mastromanno, et al.
Published: (2025-01-01)

The influence of SARS-CoV-2 vaccination on in vitro fertilization outcomes
by: Adi Anis Heusler, et al.
Published: (2025-12-01)